IMMUNEED
Live / Registered — Registered (as of 27 Feb 2024)
What this means for you
Registered since 27 Feb 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97501249
- Registration number
- 7313402
- Mark type
- Stylized text
- Filed
- 13 Jul 2022
- Published for opposition
- 12 Dec 2023
- Registered
- 27 Feb 2024
- Attorney of record
- Donna J. Bunton
Goods and services
- Class 042 — Scientific and technological services: Testing, biochemical analysis, characterization in the nature of testing to determine pharmaceutical benefits, research and development of pharmaceutical products and vaccine products for others; pharmaceutical research and development; medical and pharmacological research services; testing and analysis of immunotherapy services to assure compliance with industry standards; research and development of immunotherapy treatment methods; biochemical research; immunotherapeutic research; scientific genetics research; immunotherapeutic research in the field of drug safety and immunology; pharmaceutical drug development services; research relating to medicines; drug discovery services; laboratory research in the field of medicine, immunotherapy and cancer
Owner
- Immuneed AB, Uppsala, SE
- Immuneed AB, Uppsala, SE
- Immuneed AB, Uppsala, SE
Prosecution history
- 27 Feb 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Feb 2024 — REGISTERED-PRINCIPAL REGISTER
- 12 Dec 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Dec 2023 — PUBLISHED FOR OPPOSITION
- 22 Nov 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Nov 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Oct 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 Oct 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 26 Oct 2023 — ASSIGNED TO LIE
- 26 May 2023 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 18 May 2023 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 18 May 2023 — FINAL REFUSAL E-MAILED
- 18 May 2023 — FINAL REFUSAL WRITTEN
- 16 May 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 May 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE